Technology transfer

The stock-market debut at the end of July of Imperial College London’s tech-transfer office is the best news for academic reform in years.

Two companies that began life in laboratories at Cambridge University have merged to form a new medical diagnostics company, to be called Pronostics Ltd.

Researchers developing compounds designed to prevent allergens from entering the body are seeking investment to move to the next stage of development.

Norwegian researchers want to commercialise an easy-to-use technology that diagnoses the cause of snoring and measures the effectiveness of treatments.

The pressing need for alternative energy sources is driving investment into nanotechnology devices for energy applications such as photovoltaic solar cells.

This week the European Investment Fund took the first step in its ambitious new plan to unleash a wave of technology transfer across Europe. In doing so it endorsed a model pioneered in the UK.

On Tuesday the UK became the latest country to jump back on the nuclear energy bandwagon. But 20 years after Chernobyl, how easy is it to turn on the nuclear tap?

Less than 18 months since the policy was put in place, the UK government is reviewing progress on its approach to nanotechnology.

The European Investment Fund has partnered with UK technology commercialisation company IP Group to form a venture capital fund to invest in university spin-outs.

French researchers have developed a cell therapy that could slash the risk of rejection after bone marrow grafts to under 5 per cent, and are looking for first-round funding.